Brendan Pang
Principal Associate
Cancer
Cancer science institute of singapore
Singapore
Biography
My research interests lie in the development and clinical validation of novel biomarker assays using molecular platforms. I first forayed into cancer research when I trained under the mentorship of Professor Manuel Salto-Tellez. I furthered my training in molecular pathology as a visiting scholar at the University of Pittsburgh Medical Centre’s (UPMC) Molecular Anatomic Pathology (MAP) laboratory, Presbyterian Hospital, under Dr Marina Nikiforova, where we co-authored a paper on the novel use of COLD-PCR for the detection of low prevalence IDH1 mutant alleles in human glioma FFPE samples. On my return to Singapore, I have had research collaborations with the Genome Institute of Singapore (GIS) and other PIs from the Yong Loo Lin School of Medicine and CSI on a wide variety of projects involving the morpho-molecular evaluation of novel biomarkers in a variety of solid tumours for their predictive and prognostic significance.
Research Interest
Oncology, cancer